Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report
[ad_1] Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when its revenues moved up 2%. Revenues increased by 2% annually to $7.4 billion in the final three months of fiscal 2022. A 58% increase in international product sales more than offset weakness … Read more